Panacea Biotech shares up 56% in six sessions; Here are the latest developments
Shares of Panacea Biotec surged more than 15% in intraday trade on Tuesday, June 9, after the company announced the launch of an European Union-funded project aimed at advancing the regulatory approval and global access of its dengue vaccine candidate, DengiAll. This is the sixth straight day of gains for the stock, during which it…
